Literature DB >> 18495971

The homocysteine paradox.

Roman N Rodionov, Steven R Lentz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18495971      PMCID： PMC2430733          DOI： 10.1161/ATVBAHA.108.164830

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  20 in total

Review 1.  Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?

Authors:  Andrew G Bostom
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

2.  Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.

Authors:  S Yap; G H Boers; B Wilcken; D E Wilcken; D P Brenton; P J Lee; J H Walter; P M Howard; E R Naughten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

3.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

4.  Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.

Authors:  Martin den Heijer; Huub P J Willems; Henk J Blom; Wim B J Gerrits; Marco Cattaneo; Sabine Eichinger; Frits R Rosendaal; Gerard M J Bos
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

Review 5.  The kidney and homocysteine metabolism.

Authors:  Allon N Friedman; Andrew G Bostom; Jacob Selhub; Andrew S Levey; Irwin H Rosenberg
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

Review 6.  The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.

Authors: 
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

7.  Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.

Authors:  M Den Heijer; S Lewington; R Clarke
Journal:  J Thromb Haemost       Date:  2005-02       Impact factor: 5.824

8.  Homocysteine lowering with folic acid and B vitamins in vascular disease.

Authors:  Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

9.  Homocysteine lowering and cardiovascular events after acute myocardial infarction.

Authors:  Kaare Harald Bønaa; Inger Njølstad; Per Magne Ueland; Henrik Schirmer; Aage Tverdal; Terje Steigen; Harald Wang; Jan Erik Nordrehaug; Egil Arnesen; Knut Rasmussen
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

10.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272
View more
  13 in total

Review 1.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

2.  Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis.

Authors:  Utpal Sen; Charu Munjal; Natia Qipshidze; Oluwasegun Abe; Riyad Gargoum; Suresh C Tyagi
Journal:  Am J Nephrol       Date:  2010-04-16       Impact factor: 3.754

3.  A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing.

Authors:  Thomas G Deloughery; Beverley J Hunt; Geoffrey D Barnes; Jean M Connors
Journal:  Res Pract Thromb Haemost       Date:  2022-06-08

4.  Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.

Authors:  Roman N Rodionov; Daryl J Murry; Sarah F Vaulman; Jeff W Stevens; Steven R Lentz
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

5.  Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.

Authors:  Roman N Rodionov; Hayan Dayoub; Cynthia M Lynch; Katina M Wilson; Jeff W Stevens; Daryl J Murry; Masumi Kimoto; Erland Arning; Teodoro Bottiglieri; John P Cooke; Gary L Baumbach; Frank M Faraci; Steven R Lentz
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

6.  Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.

Authors:  Sanjana Dayal; Roman N Rodionov; Erland Arning; Teodoro Bottiglieri; Masumi Kimoto; Daryl J Murry; John P Cooke; Frank M Faraci; Steven R Lentz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

7.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

8.  Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study.

Authors:  Litao Ruan; Wei Chen; Sathanur R Srinivasan; Jihua Xu; Ahmet Toprak; Gerald S Berenson
Journal:  Eur J Epidemiol       Date:  2009-04-25       Impact factor: 8.082

9.  Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.

Authors:  J David Spence; Bradley L Urquhart; Heejung Bang
Journal:  Nephrol Dial Transplant       Date:  2015-11-14       Impact factor: 5.992

10.  Hyperhomocysteinemia-related serum metabolome alterations not normalized by short-term folic acid treatment.

Authors:  A Aneesh Kumar; Vanaja R Anusree; Gopika Satheesh; Gadadharan Vijayakumar; Mahesh Chandran; Leena Simon; Subhadra Lakshmi; Madhavan R Pillai; Abdul Jaleel
Journal:  Metabolomics       Date:  2021-05-09       Impact factor: 4.290
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.